Pauline Vaflard

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Development and external validation of a prognostic score associated with poor outcomes in patients receiving immune checkpoint blockade-containing therapies enrolled in early-phase clinical trials.

Development and external validation of a prognostic score associated with poor outcomes in patients receiving immune checkpoint blockade-containing therapies enrolled in early-phase clinical trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 10, 2026

Metastatic or unresectable recurrent anal canal cancer: Therapeutic approaches and emerging perspectives

Metastatic or unresectable recurrent anal canal cancer: Therapeutic approaches and emerging perspectives

Journal: Bulletin du cancer

Published: March 30, 2026

Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer.

Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Real-world immunotherapy outcomes in unresectable peritoneal mesothelioma: A French experience.

Real-world immunotherapy outcomes in unresectable peritoneal mesothelioma: A French experience.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 27, 2025

Upper-gastrointestinal tract toxicities associated with Immune Checkpoint Inhibitors (ICI)

Upper-gastrointestinal tract toxicities associated with Immune Checkpoint Inhibitors (ICI)

Journal: Bulletin du cancer

Published: July 01, 2025

How do doctors communicate results of genomic testing and its prognostic impact on uveal melanoma patients? Results of a qualitative study

How do doctors communicate results of genomic testing and its prognostic impact on uveal melanoma patients? Results of a qualitative study

Journal: Bulletin du cancer

Published: May 22, 2025

Considering treatments' proportionality at the advanced phase of the disease: A structuring challenge for the future of oncology

Considering treatments' proportionality at the advanced phase of the disease: A structuring challenge for the future of oncology

Journal: Bulletin du cancer

Published: May 19, 2025

Management of cancer treatment-related fatigue in advanced breast cancer patients: an expert committee's opinion.

Management of cancer treatment-related fatigue in advanced breast cancer patients: an expert committee's opinion.

Journal: Frontiers in oncology

Published: April 24, 2025

Triple negative breast cancer: Current status and perspectives

Triple negative breast cancer: Current status and perspectives

Journal: Bulletin du cancer

Published: April 30, 2024

Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list.

Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list.

Journal: Pilot and feasibility studies

Published: January 29, 2024

Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases.

Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases.

Journal: Breast cancer (Tokyo, Japan)

Published: November 29, 2023

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.

Journal: Experimental hematology & oncology

Published: March 26, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026